GM1 ganglioside exerts protective effects against glutamate‐excitotoxicity via its oligosaccharide in wild‐type and amyotrophic lateral sclerosis motor neurons
Alterations in glycosphingolipid metabolism have been linked to the pathophysiological mechanisms of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting motor neurons. Accordingly, administration of GM1, a sialic acid‐containing glycosphingolipid, is protective against neurona...
Main Authors: | Giulia Lunghi, Erika Di Biase, Emma Veronica Carsana, Alexandre Henriques, Noelle Callizot, Laura Mauri, Maria Grazia Ciampa, Luigi Mari, Nicoletta Loberto, Massimo Aureli, Sandro Sonnino, Michael Spedding, Elena Chiricozzi, Maria Fazzari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.13727 |
Similar Items
-
GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
by: Maria Fazzari, et al.
Published: (2023-04-01) -
Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition
by: Maria Fazzari, et al.
Published: (2022-02-01) -
GM1 Oligosaccharide Crosses the Human Blood–Brain Barrier In Vitro by a Paracellular Route
by: Erika Di Biase, et al.
Published: (2020-04-01) -
Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
by: Charles Finsterwald, et al.
Published: (2021-04-01) -
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease
by: Giulia Mancini, et al.
Published: (2020-06-01)